Publication | Open Access
TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PET
98
Citations
21
References
2015
Year
(89)Zr-fresolimumab penetrated recurrent high-grade gliomas very well but did not result in clinical benefit.
| Year | Citations | |
|---|---|---|
Page 1
Page 1